First Time Loading...

Oncotelic Therapeutics Inc
OTC:OTLC

Watchlist Manager
Oncotelic Therapeutics Inc Logo
Oncotelic Therapeutics Inc
OTC:OTLC
Watchlist
Price: 0.042 USD 2.94% Market Closed
Updated: Apr 28, 2024

Oncotelic Therapeutics Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oncotelic Therapeutics Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Oncotelic Therapeutics Inc
OTC:OTLC
Cash from Financing Activities
$1m
CAGR 3-Years
-34%
CAGR 5-Years
-15%
CAGR 10-Years
-20%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Oncotelic Therapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
1m USD

Based on the financial report for Sep 30, 2023, Oncotelic Therapeutics Inc's Cash from Financing Activities amounts to 1m USD.

What is Oncotelic Therapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-20%

Over the last year, the Cash from Financing Activities growth was -60%. The average annual Cash from Financing Activities growth rates for Oncotelic Therapeutics Inc have been -34% over the past three years , -15% over the past five years , and -20% over the past ten years .